ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,655
Screening encounters
4,264
Diagnostic referrals
812
Outstanding pathways
293

Screening pathway

  1. Screening4,264Encounters
  2. Positive finding1,469Documented findings
  3. Referral812Diagnostic referrals
  4. Follow-up953Diagnostic visits
  5. Outcome519Resolved pathways

Stage totals use different units. Pending pathways: 293. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2425 · EXP-2425Synthetic · Site A

Full participant history through 2026-10-13, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2027-07-19

Referral-time risk

No matching referral was available at this observation date.

Screened participants

3655 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1905 · Expanded synthetic participant 1905Site C — Rural Outreach Programme
EXP-1906 · Expanded synthetic participant 1906Site C — Rural Outreach Programme
EXP-1908 · Expanded synthetic participant 1908Site D — Community Engagement Programme
EXP-1909 · Expanded synthetic participant 1909Site A — Urban Referral Hub
EXP-1910 · Expanded synthetic participant 1910Site D — Community Engagement Programme
EXP-1912 · Expanded synthetic participant 1912Site B — Peri-Urban Access Programme
EXP-1913 · Expanded synthetic participant 1913Site E — Resource-Constrained Navigation Programme
EXP-1914 · Expanded synthetic participant 1914Site B — Peri-Urban Access Programme
EXP-1917 · Expanded synthetic participant 1917Site D — Community Engagement Programme
EXP-1918 · Expanded synthetic participant 1918Site B — Peri-Urban Access Programme
EXP-1919 · Expanded synthetic participant 1919Site A — Urban Referral Hub
EXP-1920 · Expanded synthetic participant 1920Site A — Urban Referral Hub
EXP-1922 · Expanded synthetic participant 1922Site C — Rural Outreach Programme
EXP-1923 · Expanded synthetic participant 1923Site B — Peri-Urban Access Programme
EXP-1924 · Expanded synthetic participant 1924Site D — Community Engagement Programme
EXP-1925 · Expanded synthetic participant 1925Site D — Community Engagement Programme
EXP-1926 · Expanded synthetic participant 1926Site C — Rural Outreach Programme
EXP-1931 · Expanded synthetic participant 1931Site C — Rural Outreach Programme
EXP-1932 · Expanded synthetic participant 1932Site B — Peri-Urban Access Programme
EXP-1933 · Expanded synthetic participant 1933Site C — Rural Outreach Programme
EXP-1934 · Expanded synthetic participant 1934Site E — Resource-Constrained Navigation Programme
EXP-1936 · Expanded synthetic participant 1936Site A — Urban Referral Hub
EXP-1937 · Expanded synthetic participant 1937Site A — Urban Referral Hub
EXP-1939 · Expanded synthetic participant 1939Site D — Community Engagement Programme
EXP-1940 · Expanded synthetic participant 1940Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1659
HPV DNA
2006
Cytology
599

Navigation activity

Barrier documented
716
Contact attempt
1189
Navigation intervention
306
Diagnostic booking
1008
Diagnostic visit
953

Documented barriers

Contact difficulty
230
Transport difficulty
233
Appointment coordination
253

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.